X-Received: by 2002:adf:fb91:0:b0:21b:89b5:20 with SMTP id a17-20020adffb91000000b0021b89b50020mr10420210wrr.74.1656301927929;
Sun, 26 Jun 2022 20:52:07 -0700 (PDT)
X-Received: by 2002:a81:5a82:0:b0:318:52ce:8f7b with SMTP id
o124-20020a815a82000000b0031852ce8f7bmr12744535ywb.228.1656301927381; Sun, 26
Jun 2022 20:52:07 -0700 (PDT)
Path: i2pn2.org!i2pn.org!weretis.net!feeder8.news.weretis.net!proxad.net!feeder1-2.proxad.net!209.85.128.87.MISMATCH!news-out.google.com!nntp.google.com!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: rec.music.gdead
Date: Sun, 26 Jun 2022 20:52:07 -0700 (PDT)
Injection-Info: google-groups.googlegroups.com; posting-host=208.78.41.151; posting-account=XSirDwoAAAADOU56A24BSwoltzp-uhEo
NNTP-Posting-Host: 208.78.41.151
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <0634cc8d-863e-4d40-b324-673795175d3dn@googlegroups.com>
Subject: (PDF) Landmark Trials in Oncology by Santosh Yajnik
From: hesterholt3@gmail.com (hester holt)
Injection-Date: Mon, 27 Jun 2022 03:52:07 +0000
Content-Type: text/plain; charset="UTF-8"